May 28, 2014 / 10:35 AM / in 3 years

Valeant increases bid for Botox-maker Allergan

May 28 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc raised the cash component of its offer for Botox-maker Allergan Inc by $10 per share.

Valeant on Wednesday offered to pay $58.30 per Allergan share in cash, about 21 percent higher than its previous offer of $48.30.

The stock component of the offer remains the same at 0.83 of a Valeant share for each to Allergan share held.

Valeant and activist investor Bill Ackman had made an unsolicited $47 billion bid to buy Allergan on April 22, which Allergan spurned. (Reporting by Esha Dey in Bangalore; Editing by Savio D‘Souza)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below